BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 4th Quarter - Termination

MOLECULAR INSIGHT PHARMACEUTICALS

via JEFFREY J. KIMBELL & ASSOCIATES, INC.

4th Quarter (Oct 1 - Dec 31) · 2008Posted Jan 20, 2009Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: MOLECULAR INSIGHT PHARMACEUTICALS
Description: Pharmaceutical Research
Location: Massachusetts · United States of America

Registrant

Firm: JEFFREY J. KIMBELL & ASSOCIATES, INC.
Description: Consulting Firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
GENERAL HEALTH CARE ISSUES, REIMBURSEMENT ISSUES
LobbyistsAARON COHEN · mrs JENNIFER VESEY ROSSMAN · mr JEFFREY J KIMBELL · JODIE LOCKHART
Covered position (AARON COHEN): POLICY ADVISOR, SEN. ENSIGN & BRYAN
Covered position (mrs JENNIFER VESEY ROSSMAN): POLICY ADVISOR, SEN. RICK SANTORUM
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

MOLECULAR INSIGHT PHARMACEUTICALS — Receipts Report